Fidelity US High Quality Currency Neutral ETF (FCQH) News

None of the abstract/poster deadlines are super relevant. How many times have they submitted a poster at ASCO? Probably once in the last 7-8 years?
well if they were not planning anything that cost thinking labour, as I assumed, just the registration and a hotel booking, then they were lying

I was indeed interested in taking a position in Alzheon if it became possible. In my opinion similar to $AVXL Alzheon have a different approach in their case actual precision medicine addressing only APOE4/4 high risk of AD patients with an oral compound that avoids the MABS safety issues and inconv

He is a paid low life fudster. I like your description as gutter ball. Have to remember that one.

Goods Imported From China Now Face 54% Tariff Rate · Goods imported from China will now face a combined total tariff rate of 54%, Treasury Secretary Scott Bessent said Wednesday.

https://article.wn.com/view/2025/04/03/Goods_imported_from_China_now_face_a_54_tariff_rate/

Over 1,300 00 protests are planned for today in all 50 states interesting day

another wrap up FYI,

https://youtu.be/j-jROh_aHY8?si=52s2FFga6o-P7ZPF

https://stockcharts.com/h-sc/ui?s=DRIP&p=D&yr=0&mn=6&dy=1&id=p78622490611

https://investorshub.advfn.com/uimage/uploads/2025/4/5/fzkcm5Apr1.png


My road map for th

Total sense, Genz2!

Dave can we put the ‘next’ button back where it belongs, where it has been forever , in the upper right hand? Why was this change made today ? It makes reviewing posts more difficult

Thank you

If AFFU is conducting a Reverse Acquisition now.
They better get there rear in gear and clean up the deception. Or else face the music. They can't announce an acquisition then call it a Reverse Acquisition in the same context.

Under IFRS 3, the accounting acquirer (MTi) is de

Or open the hood plant some flowers in it use it for yard art in front of the White House

There is nothing on this board what hasn’t been discussed or is helping the company in any way or even ourselves. All of us are doing our utmost to understand company progress. Personally I have every reason to believe the new management will deliver as promised. Here some lines to understand a bit

Remember, this means both Domestic And Foreign: careful what we say in a free speech country?

https://www.law.cornell.edu/uscode/text/50/1702

You want to be fake and act like you care… but you are no different. You do not give two chits. Being sneaky like that is actually worse

IBD 50 includes ANIP as one of 50 defensive stocks during the market plunge we are experiencing. It is one of 44 stocks that have held up well in comparison to the markets.

IBD 50 identifies 50 growth stocks showing strong relative price strength and top-notch fundamentals found in

The only reason many are in this mess is Lebby overstating and overpromising for years, nothing else! If he had been honest and told the truth, many would have sold already and took the gains they had back then to step back in later when he really had something to bring to the table!! We were mislea

tnyellowtomcat “I think LQMT has done remarkably well, considering the general stock market crash that has taken place this week.”

A. The market hasn’t crashed
B. LQMT is not doing very well. It’s still down.
C. When was the last time you were in the green?
D. C

Let's face it.. lightwave needs a buyout from a big game player To have a chance of adoption now. Yves hopes of a good price seem to get smaller and smaller every week. OFC just proved there's many other options .. just as good that will tick over for the next half a decade. Lebby absolutely train c

My3sons, i'm not. I used to have a strong position regarding my portfolio and still believe in IDCC. I will be back before the end of the month, probably second half of April, after Europe's coercive responses .  May be i'm wrong, but i'm careful. 

$IBO as a reminder, the good update from last year and a recovery should come next week, imho
https://ih.advfn.com/stock-market/AMEX/impact-biomedical-IBO/stock-news/94943528/impact-biomedical-inc-issues-shareholder-letter-h